Glycosylated Hemoglobin Test Health Article

Definition

Glycosylated hemoglobin is a test that indicates how much sugar has been in a person's blood during the past two to four months. It is used to monitor the effectiveness of diabetes treatment.

Purpose

Diabetes is a disease in which a person cannot effectively use sugar in the blood. Left untreated, blood sugar levels can be very high. High sugar levels increase risk of complications, such as damage to eyes, kidneys, heart, nerves, blood vessels, and other organs.

A routine blood sugar test reveals how close to normal a sugar level is at the time of the test. The glycosylated hemoglobin test reveals how close to normal it has been during the past several months.

This information helps a physician evaluate how well a person is responding to diabetes treatment and to determine how long sugar levels have been high in a person newly diagnosed with diabetes.

Description

The Diabetes Control and Complications Trial (DCCT) demonstrated that persons with diabetes who maintained blood glucose (sugar) and total fasting hemoglobin levels at or close to a normal range decreased their risk of complications by 50–75%. Based on results of this study, the American Diabetes Association (ADA) recommends routine glycosylated hemoglobin testing to measure long-term control of blood sugar.

Glycosylated hemoglobin measures the percentage of hemoglobin bound to glucose. Hemoglobin is a protein found in every red blood cell. As hemoglobin and glucose are together in the red blood cell, the glucose gradually binds to the A1c form of hemoglobin in a process called glycosylation. The amount bound reflects how much glucose has been in the blood during the past average 120-day lifespan of red cells.

Several methods are used to measure the amount of bound hemoglobin and glucose. They are electrophoresis, chromatography, and immunoassay. All are based on the separation of hemoglobin bound to glucose from that without glucose.

The ADA recommends glycosylated hemoglobin be done during a person's first diabetes evaluation, again after treatment is begun and sugar levels are stabilized, then repeated semiannually. If the person does not meet treatment goals or sugar levels have not stabilized, the test should be repeated quarterly.

Other names for the test include: Hemoglobin A1c, Diabetic control index, GHb, glycosylated hemoglobin, and glycated hemoglobin. The test is covered by insurance. Results are usually available the following day.